Cargando…

Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency

OBJECTIVE: CblC deficiency, the most common cobalamin metabolic abnormality, is caused by pathogenic variants in the MMACHC gene. The renal complications of this disease have been described only in a small number of cases. This study aimed to better delineate renal phenotype and genetic characterist...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoyu, Xiao, Huijie, Yao, Yong, Wang, Suxia, Zhang, Hongwen, Zhong, Xuhui, Yang, Yanling, Ding, Jie, Wang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871484/
https://www.ncbi.nlm.nih.gov/pubmed/36704130
http://dx.doi.org/10.3389/fped.2022.1057594
_version_ 1784877183786811392
author Liu, Xiaoyu
Xiao, Huijie
Yao, Yong
Wang, Suxia
Zhang, Hongwen
Zhong, Xuhui
Yang, Yanling
Ding, Jie
Wang, Fang
author_facet Liu, Xiaoyu
Xiao, Huijie
Yao, Yong
Wang, Suxia
Zhang, Hongwen
Zhong, Xuhui
Yang, Yanling
Ding, Jie
Wang, Fang
author_sort Liu, Xiaoyu
collection PubMed
description OBJECTIVE: CblC deficiency, the most common cobalamin metabolic abnormality, is caused by pathogenic variants in the MMACHC gene. The renal complications of this disease have been described only in a small number of cases. This study aimed to better delineate renal phenotype and genetic characteristics in Chinese children with cblC defect. METHODS: Children with cblC deficiency who manifested as kidney damage were enrolled. Clinical, renal pathological, and genetic data were reviewed in detail. RESULTS: Seven cases were enrolled. Ages at disease onset ranged from 9 months to 5 years. All patients presented with hematuria and proteinuria, and 2/7 cases presented with nephrotic syndrome. Renal dysfunction was observed in 4/7 cases. Renal biopsy was performed in 5/7 cases, and all of them had renal thrombotic microangiopathy. Macrocytic anemia was detected in all seven patients. Six out of seven cases had hypertension, and 2/7 cases presented with pulmonary hypertension. Two of them had a mild intellectual disability, and one suffered from epilepsy. Increased urine methylmalonic acid and plasma homocysteine were detected in seven cases, while two patients had normal levels of urine methylmalonic acid at the initial evaluation. After diagnosis, all seven cases were treated with hydroxocobalamin IM. Six cases were followed-up for 3–8 years. After treatments, anemia was the first to be recovered, followed by proteinuria. Renal function recovered after 1 year in two cases, whereas patient 2 progressed to stage 2 chronic kidney disease 13 years after onset. While a case presented with end-stage kidney disease because of late diagnosis, one case died 3 months after disease onset due to giving up treatment. Three MMACHC pathogenic variants c.80A > G (8/14), c.609G > A (4/14), and c.658_660delAAG (2/14) were detected in all seven children. CONCLUSION: MMACHC variant c.80A > G may be associated with prominent renal complications in Chinese cblC patients. Macrocytic anemia and hyperhomocysteinemia are useful clues for patients with hematuria and proteinuria caused by cblC defect. The most frequent renal pathological manifestation is thrombotic microangiopathy. Early diagnosis and treatment resulted in improving renal and hematological signs.
format Online
Article
Text
id pubmed-9871484
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98714842023-01-25 Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency Liu, Xiaoyu Xiao, Huijie Yao, Yong Wang, Suxia Zhang, Hongwen Zhong, Xuhui Yang, Yanling Ding, Jie Wang, Fang Front Pediatr Pediatrics OBJECTIVE: CblC deficiency, the most common cobalamin metabolic abnormality, is caused by pathogenic variants in the MMACHC gene. The renal complications of this disease have been described only in a small number of cases. This study aimed to better delineate renal phenotype and genetic characteristics in Chinese children with cblC defect. METHODS: Children with cblC deficiency who manifested as kidney damage were enrolled. Clinical, renal pathological, and genetic data were reviewed in detail. RESULTS: Seven cases were enrolled. Ages at disease onset ranged from 9 months to 5 years. All patients presented with hematuria and proteinuria, and 2/7 cases presented with nephrotic syndrome. Renal dysfunction was observed in 4/7 cases. Renal biopsy was performed in 5/7 cases, and all of them had renal thrombotic microangiopathy. Macrocytic anemia was detected in all seven patients. Six out of seven cases had hypertension, and 2/7 cases presented with pulmonary hypertension. Two of them had a mild intellectual disability, and one suffered from epilepsy. Increased urine methylmalonic acid and plasma homocysteine were detected in seven cases, while two patients had normal levels of urine methylmalonic acid at the initial evaluation. After diagnosis, all seven cases were treated with hydroxocobalamin IM. Six cases were followed-up for 3–8 years. After treatments, anemia was the first to be recovered, followed by proteinuria. Renal function recovered after 1 year in two cases, whereas patient 2 progressed to stage 2 chronic kidney disease 13 years after onset. While a case presented with end-stage kidney disease because of late diagnosis, one case died 3 months after disease onset due to giving up treatment. Three MMACHC pathogenic variants c.80A > G (8/14), c.609G > A (4/14), and c.658_660delAAG (2/14) were detected in all seven children. CONCLUSION: MMACHC variant c.80A > G may be associated with prominent renal complications in Chinese cblC patients. Macrocytic anemia and hyperhomocysteinemia are useful clues for patients with hematuria and proteinuria caused by cblC defect. The most frequent renal pathological manifestation is thrombotic microangiopathy. Early diagnosis and treatment resulted in improving renal and hematological signs. Frontiers Media S.A. 2023-01-10 /pmc/articles/PMC9871484/ /pubmed/36704130 http://dx.doi.org/10.3389/fped.2022.1057594 Text en © 2023 Liu, Xiao, Yao, Wang, Zhang, Zhong, Yang, Ding and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Liu, Xiaoyu
Xiao, Huijie
Yao, Yong
Wang, Suxia
Zhang, Hongwen
Zhong, Xuhui
Yang, Yanling
Ding, Jie
Wang, Fang
Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
title Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
title_full Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
title_fullStr Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
title_full_unstemmed Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
title_short Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
title_sort prominent renal complications associated with mmachc pathogenic variant c.80a > g in chinese children with cobalamin c deficiency
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871484/
https://www.ncbi.nlm.nih.gov/pubmed/36704130
http://dx.doi.org/10.3389/fped.2022.1057594
work_keys_str_mv AT liuxiaoyu prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT xiaohuijie prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT yaoyong prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT wangsuxia prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT zhanghongwen prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT zhongxuhui prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT yangyanling prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT dingjie prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency
AT wangfang prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency